We provide sequencing services on cutting-edge next generation sequencing (NGS) platforms, including proprietary DNBSEQ™ technology platforms offering quality data at unrivaled pricing for a wide variety of sequencing services and clinical applications. We offer one of the industry's largest sequencing capacities and have a wide variety of other NGS platforms to meet all our customers' needs. Our technology, sequencing capacity and more than 20 years of genomics experience allow us to offer our customers and partners a trusted, cost efficient and expert service for all outsourced sequencing needs.
DNBSEQ-T7 can generate 1-6Tb of high quality data per day, for a wide range of applications including Whole Genome Sequencing, Deep Exome Sequencing, Epigenome Sequencing, Transcriptome Sequencing, and targeted panel projects. Powered by DNBSEQ™ Technology, DNBSEQ-T7 makes sequencing more efficient and productive with advances.
DNBSEQ-G400 is built with a new chip system that can flexibly support a variety of different sequencing modes. It adopts optimized optical and biochemical systems, which can complete the sequencing process rapidly, giving users a more streamlined sequencing experience.
DNBSEQ-G50 is a highly efficient and targeted sequencer, with a number of total solutions based on different applications. The DNBSEQ-G50 platform, together with the automated library preparation system MGISP-100, provides a wide range of throughputs and flexible turnaround times, satisfying various clinical and research applications such as targeted DNA & RNA sequencing, pathogen identification and small panel sequencing.
The PacBio Sequel System platform is based on PacBio’s proven Single Molecule, Real Time (SMRT) sequencing technology. This SMRT sequencing on the PacBio Sequel combines long read technology and rapid sequencing with 7 times higher throughput compared to previous systems for the highest-quality data. The PacBio Sequel is ideal for whole genome de novo assembly projects that require higher-quality data, microbial genome assembly, identifying DNA modications without bisulfite treatment, and identifying large structural variants. The system delivers up to 99.999% accuracy.
PromethION offers the same real-time, long-read, direct DNA and RNA sequencing technology as MinION and GridION, at much larger scale. You may find PromethION suitable for large scale projects.
DNBSEQ is a registered trademark of MGI.
All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. All specifications are subject to change without notice.